Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
about
Tenascin-X is a novel diagnostic marker of malignant mesotheliomaLow-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthaseLow molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplificationPolyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.Too much cleavage of cyclin E promotes breast tumorigenesis.Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast CancerAltered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation.New diagnostic and molecular characteristics of malignant mesothelioma.The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.17beta-estradiol induces both up-regulation and processing of cyclin E in a calpain-dependent manner in MCF-7 breast cancer cells.AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.
P2860
Q24649948-B102A12C-4338-4A3E-8014-8F33195C01A7Q33658276-FB1F969B-3857-4565-9AAE-18C7CA7A3B8CQ33888942-BBD06051-4127-4B07-819A-46CC8B494C42Q33925994-5E8437F0-E611-485B-9016-833925CEABF9Q34062677-BDD480CA-1CDC-434B-A42D-80340C797649Q34221065-96F983E2-3828-42FF-85CB-E979581267E4Q35158463-4DA57B3B-6979-4F4A-844B-0C756415458CQ35576881-66059B37-A744-4266-B373-667ECA4EE56BQ36182188-576F7B64-B1FA-4BE0-820E-D55CC21C650CQ36291421-D7454D07-E0FC-49AD-A7C7-5D679E0CF2DFQ36918276-CBB07096-FA4B-4D3A-B22F-A48EEE2B4DB7Q37057171-0C588B54-6863-4394-A02B-6A280573545CQ37160444-CA0D198F-FF36-4122-B175-2F72F13B4C3BQ37360580-20145072-19EE-442E-BC67-AF93761A1B5BQ37813173-EB98EE74-9DE5-4F12-9196-53BB1EEE1584Q39373705-DE92612B-DD77-4F04-A058-62E0C5EF0AE8Q39745596-E9F3AE70-972C-489D-84FE-34C3D583CB08Q43429196-C1E5962D-6F79-4B00-AE0C-0291AB638918Q48148897-27BC8930-A7B1-42DF-B112-F982FDA8B7AEQ49558301-319553A3-1034-4BE3-9D19-1A83647B0CB9Q52955581-9B8FFC9A-63F9-4574-9D71-91150F1BEEFD
P2860
Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@en
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@nl
type
label
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@en
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@nl
prefLabel
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@en
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@nl
P2093
P356
P1433
P1476
Low-molecular weight forms of ...... survival in ovarian carcinoma.
@en
P2093
Ben Davidson
Ie-Ming Shih
Ilvars Silins
Martina Skrede
Vivi Ann Flørenes
P304
P356
10.1002/CNCR.22918
P407
P577
2007-09-01T00:00:00Z